Fourlanos et al developed a clinical screening tool to help identify adults with latent autoimmune diabetes mellitus (LADA). This can select patients for additional testing to detect islet cell autoantibodies. The authors are from the Walter and Eliza Hall Institute of Medical Research in Parkville, Victoria, Australia.
